Comprehensive Guide to Health Conditions for Life Insurance Qualification

Citizens Life Group, an Orlando-based brokerage, has released a guide that clarifies the health conditions qualifying a life insurance policy for sale, aligning with federal and state certification standards.

The newly published guide, available since August 23, offers detailed insights into qualifying conditions like cancer and heart failure. However, it primarily organizes information based on legislative criteria rather than simply listing diseases. This strategic approach stems from the complex nature of federal regulations that do not enumerate specific diseases as qualifiers for life insurance policy sales. Instead, conditions such as terminal illness are defined under section 101(g) of the Internal Revenue Code as when a physician anticipates the patient's death within 24 months. Chronic illness is similarly identified by section 7702B as the inability to perform at least two out of six key daily activities for a minimum of 90 days or by suffering from severe cognitive impairment.

Understanding State-Level Variability

State laws frequently echo these federal definitions, often aligning with the Viatical Settlements Model Act formulated by the National Association of Insurance Commissioners. However, a notable aspect of this legislative framework is its acknowledgment of state-specific variations. Hence, simply being diagnosed with a condition such as cancer doesn't automatically qualify a policy for a viatical or life settlement. Each case requires an examination of life expectancy and disease stability.

Beyond Single Diagnoses: Evaluating Combined Risk Profiles

One key takeaway from Citizens Life Group's guide is the realization that qualifying conditions are often less severe than expected. In many cases, aging individuals with multiple manageable conditions, such as heart disease and diabetes, may create a combined risk profile that significantly impacts life expectancy assessments. The emphasis is placed not on the presence of a specific disease but on an overarching evaluation of recent medical history.

Insights from Industry Experts

According to Cole Hallman, Managing Partner at Citizens Life Group, "There is a misconception that a specific diagnosis must appear on a qualifying list. Instead, underwriters focus on recent medical history."

This perspective is underscored by industry data from the Life Insurance Settlement Association, indicating that policy sellers in 2025 earned an average of $212,066 through life settlements, significantly exceeding the typical cash surrender value. The industry managed approximately 2,955 transactions, dispensing over $626.6 million in total that year. These figures illustrate the financial advantages of exploring life settlements.

Practical Steps for Policyholders

Jeff Hallman, Managing Director at Citizens Life Group, cautions that a diagnosis alone doesn't make a policy automatically eligible for sale. Prospective sellers are encouraged to explore potential early payouts using accelerated death benefit riders and compare them with life settlement offers to make informed decisions.

The guide and further resources, including a video explainer on viatical settlements, are accessible through Citizens Life Group's digital platforms. With transparent practices, no upfront costs, and compliance with state licensing requirements, the company aims to serve policy sellers effectively across various states.